# The Phoenix Review: $879 for a Therapy the FDA Has Not Cleared

> The Phoenix sells an at-home version of a clinic treatment that is itself still investigational — and the waves it produces are not the waves the trials used. The lowest score we have given anything on this site.

- **Source:** ED Treatment Guides (https://www.edtreatmentguides.com/the-phoenix-reviews)
- **Last updated:** 2026-08-02
- **Type:** review
- **Service:** The Phoenix
- **What it is:** Consumer acoustic-wave device sold direct to the public for home use. No prescription and no clinician involved
- **Editorial rating:** 2.6/5
- **Best for:** Honestly: very few people. Men who have exhausted evidence-based options, understand the therapy is investigational, and can lose $879 without it mattering.
- **Medications offered:** The Phoenix — a handheld acoustic wave device with applicator heads; No medication. No clinical supervision
- **Availability:** Sold nationwide direct to consumers. There is no prescriber, and no clinician reviews whether the treatment is appropriate for you.
- **Website:** https://www.getmyphoenix.com/
- **Commercial relationship:** No commercial relationship. Links to this service earn us nothing.

## Key points

- Low-intensity shockwave therapy for ED is **investigational** — the AUA guideline places it under research protocols, not routine care.
- The Phoenix is **not FDA-cleared to treat erectile dysfunction**, whatever the marketing implies about 'FDA-cleared ranges'.
- The trials used **focused shockwaves**; consumer handhelds generally produce **radial pressure waves**. Different physics, and evidence for one is not evidence for the other.
- **$879** (around $704 on promotion) with no clinician assessing whether you are even a candidate.
- The same money buys roughly **twenty years of generic tadalafil**, which is guideline first-line treatment.

## Scores

| Criterion | Score | Note |
| --- | --- | --- |
| Clinical quality | 2/5 | Low-intensity shockwave therapy for ED is investigational — the AUA guideline says it should be used under research protocols. That is the clinic version. The consumer version compounds the problem: the trials used focused shockwaves at controlled energy levels delivered by a trained operator, and a handheld consumer device is not that machine. |
| Transparency | 2/5 | Marketing implies FDA involvement that does not exist for this indication, using phrases about staying 'within FDA-cleared ranges' that sound like clearance without being it. The device is not FDA-cleared to treat erectile dysfunction, and that is the fact a buyer needs on the first screen rather than in a footnote. |
| Value | 2.2/5 | $879, or around $704 on promotion, with financing at roughly $29–$43 a month. Cheaper than a course of in-office sessions at $400–$600 each, which is the comparison the marketing invites — but that comparison only works if the two things do the same thing, and the evidence that they do is missing. |
| Experience | 3.5/5 | The hardware itself is reportedly well made and the protocol is easy to follow at home, which is the point of the product. Marked down because 'easy to self-administer' is a smaller virtue when nobody has established what you should be self-administering. |
| Privacy | 4/5 | A one-off purchase of a physical object with no questionnaire, no prescriber and no health record. The main exposure is an $879 line on a card statement and whatever the company does with a marketing email address. |

**Overall: 2.6/5**

## Pros

- One-off purchase, cheaper than a course of in-office shockwave sessions
- No drugs, so no interactions — including none with nitrates
- Reusable indefinitely and shareable, so the per-use cost falls with time
- No prescription, no consultation, no subscription
- The underlying idea — stimulating new blood vessel growth — is a legitimate research direction

## Cons

- **Low-intensity shockwave therapy for ED is investigational**, and the AUA guideline says it belongs in research protocols
- **Not FDA-cleared to treat erectile dysfunction.** Marketing language about 'FDA-cleared ranges' is not the same thing
- Consumer devices deliver radial pressure waves, not the focused shockwaves used in the trials
- $879 with no clinician assessing whether you are even a candidate
- Will not help post-surgical or severe neurogenic ED, where the mechanism does not apply
- Money spent here is money not spent on things that are proven to work

## Pricing

| Plan | Price | Includes |
| --- | --- | --- |
| The Phoenix | About $879 | Device, applicator heads, instructions. One-off purchase |
| On promotion | Around $704 | Discounted price seen frequently. Financing quoted at roughly $29–$43 a month |
| In-office shockwave, for scale | $400–$600 per session, typically 6+ sessions | Focused shockwaves, trained operator, clinical assessment. Also investigational, and rarely covered by insurance |
| Generic tadalafil, for scale | About $20–$40 for 90 days | Strong evidence, guideline first-line, roughly one fortieth of the price |

_Prices checked 2026-08-02. Verify on the provider's own site before ordering._

## Verdict

This is the lowest score we have given anything, and it is not because the device is a scam — it is because of a stack of gaps that each sound small and are not. Start at the top. Low-intensity shockwave therapy for erectile dysfunction is not established treatment. The AUA's guideline places it in the investigational category and says it should be offered under research protocols, because although the mechanism is plausible — acoustic energy prompting new blood vessel growth in penile tissue — the trials are small, short, heterogeneous and often unblinded. That is the state of the evidence for the *clinic* version, administered by a trained operator with a machine costing thousands. The Phoenix is a consumer product, and here is the technical point that the marketing does not address: the studies used **focused shockwaves**, generated and aimed to deliver a defined energy density at a defined depth. Consumer handhelds in this price range generally produce **radial pressure waves**, which spread from the surface and lose energy with depth. They are not the same physical phenomenon, and evidence for one is not evidence for the other. Then the regulatory layer. The Phoenix is not FDA-cleared to treat erectile dysfunction. Language about energy output being 'within FDA-cleared ranges for acoustic therapy' is doing a lot of work in a sentence that never quite makes the claim. What all of this adds up to is $879, spent without anyone assessing whether you are a candidate, on a home version of a therapy that is still investigational in clinics. If you have genuinely exhausted the evidence-based options, understand exactly what you are buying, and can afford to lose the money, it is your call to make. For nearly everyone else, $879 buys about twenty years of generic tadalafil.

## The idea, which is not a stupid one

It is worth starting with what is genuinely interesting here, because the pitch is not nonsense. Almost every treatment for erectile dysfunction manages the symptom: a tablet dilates blood vessels for a few hours, a pump produces an erection now, a ring holds one. None of them changes the underlying tissue. The proposition behind shockwave therapy is different — that pulses of acoustic energy applied to penile tissue trigger a healing response, including angiogenesis, the growth of new blood vessels. If that worked reliably, it would be the first widely available treatment that improved the plumbing rather than working around it.

That is a real research direction with real published studies behind it, and our [shockwave therapy page](https://www.edtreatmentguides.com/treatments/shockwave-therapy) covers where the evidence stands. The short version: some trials show benefit, particularly in men with vasculogenic ED who still respond partially to PDE5 inhibitors; the trials are mostly small, short, and inconsistent in protocol; sham-controlled results are weaker than open-label ones; and durability past a year is poorly established.

> **What the guideline says**
>
> The AUA's erectile dysfunction guideline treats low-intensity shockwave therapy as **investigational** and advises that it be used under research protocols. That is not a dismissal — it is a statement that the evidence is not yet good enough to recommend it as care. Everything below follows from that starting point, because a home device cannot have better evidence than the clinical procedure it imitates.

## The technical problem: focused versus radial

This is the part of the analysis that changes the conclusion, and it is almost never explained to buyers. 'Shockwave' and 'acoustic wave' get used interchangeably in marketing. In physics and in the trials, they are not interchangeable.

**Two different things sold under similar names**

|  | Focused shockwave | Radial pressure wave |
| --- | --- | --- |
| How it is generated | Electrohydraulic, electromagnetic or piezoelectric, then focused to a point | A projectile striking an applicator, spreading outward from the surface |
| Energy at depth | Concentrated at a defined focal depth | Highest at the skin, falling away rapidly with depth |
| Used in the ED trials | Yes — this is what the published studies used | Largely not |
| Typical setting | Clinic, trained operator, machine costing thousands | Consumer handhelds and physiotherapy massage devices |

_Manufacturers do not always specify which type a consumer device produces. If a product does not state it plainly, ask before buying — it is the single most informative question you can put to a seller in this category._

The consequence is straightforward. If the mechanism depends on delivering a particular energy density to tissue at depth, and a device delivers something weaker that dissipates near the surface, then the trials of the first device tell you very little about the second. The marketing bridges that gap by talking about shockwave therapy in general and then selling you a handheld. The evidence does not bridge it.

> **The question to ask any seller**
>
> "Is this focused or radial, and what energy density does it deliver at what depth?" A company with a defensible product will answer directly. An answer that redirects to testimonials, or to studies of a different machine, is itself the answer.

## What the FDA has and has not said

> **Not cleared for erectile dysfunction**
>
> No low-intensity shockwave device is FDA-approved or cleared specifically to treat erectile dysfunction in the United States. That includes the machines in clinics and it includes The Phoenix. Marketing that says energy output stays 'within safe, FDA-cleared ranges for acoustic therapy' is constructed to sound like clearance for this use. It is not one.

This matters beyond pedantry. Clearance for an indication is the mechanism by which somebody outside the company checks that the claimed benefit is supported. Without it, the only quality control on the claim is the company making it, and the FTC's guidance on health claims is the only backstop. When a device is sold for a use it has not been authorised for, you are the trial.

It also affects what happens if something goes wrong. There is no prescriber, no assessment of whether you are a candidate, and no clinician who knows you have been doing this. Men with [Peyronie's disease](https://www.edtreatmentguides.com/causes/peyronies-disease), penile implants, bleeding disorders, active infection, or anyone on anticoagulants should not be self-administering acoustic energy without medical advice, and a website that sells to anyone with a card is not going to establish which of those apply to you.

## Where the $879 could go instead

Opportunity cost is the strongest argument here, stronger than any objection to the device itself. Money spent on an investigational home treatment is money not spent on things with settled evidence — and in this field, the proven options are cheap.

**What $879 buys elsewhere**

| Instead | Roughly what it costs | Evidence |
| --- | --- | --- |
| Generic tadalafil, daily, for years | $20–$40 for 90 days | Strong — guideline first-line |
| Medical-grade vacuum device | $100–$500 one-off | Strong — around 90% achieve a usable erection |
| A urology consultation and workup | $150–$400 without insurance | Finds the cause instead of guessing at it |
| Sex therapy, several sessions | $100–$250 per session | Strong for psychogenic and mixed ED |
| Pelvic floor physiotherapy | $80–$200 per session, often a handful | Randomised trial evidence, particularly for venous leak |

_Prices are US cash prices and vary widely. Model your own with the [cost calculator](https://www.edtreatmentguides.com/tools/cost-calculator)._

> **If you still want to try shockwave**
>
> Do it the way the evidence was generated: in a clinic, with focused shockwaves, after a urologist has assessed whether your ED is vasculogenic — which is the subgroup where the published benefit sits. It costs more and it is still investigational, but at least it is the thing that was studied, and someone qualified is deciding whether you are a candidate. Better still, ask about enrolling in a trial through [ClinicalTrials.gov](https://clinicaltrials.gov/).

## The narrow case for buying one anyway

We are not going to pretend nobody should ever buy this. There is a narrow set of circumstances where it is a defensible choice, and it is worth stating them plainly rather than leaving the review as a wall of objections.

- You have **vasculogenic ED** — the blood-flow kind — confirmed by a clinician, rather than post-surgical nerve damage or a hormonal cause. That is the only group the published benefit has been seen in.
- You have already tried PDE5 inhibitors and either they help partially or you cannot take them.
- You understand you are buying something investigational, and you are not going to conclude the world is against you when it does not work.
- **$879 is money you can lose.** Not money you are moving from something else you need.
- You have told a clinician you are doing it, so it is on your record if a problem arises.

> **Do not use it if**
>
> You have a penile implant, active infection, an untreated bleeding disorder, are on anticoagulants without medical advice, have [Peyronie's disease](https://www.edtreatmentguides.com/causes/peyronies-disease) or any penile lesion that has not been assessed, or have a cancer diagnosis involving the area. Applying acoustic energy to tissue is not risk-free, and there is no clinician in this transaction to tell you so.

## Frequently asked questions

### Is The Phoenix FDA approved?

No. No low-intensity shockwave device is FDA-approved or cleared to treat erectile dysfunction in the US, including the machines used in clinics. Marketing language about staying 'within FDA-cleared ranges for acoustic therapy' is not a clearance for treating ED, and it is worded to be heard as one.

### Does at-home shockwave therapy work for ED?

There is no good evidence that a consumer handheld does. The clinical trials used focused shockwaves delivered by clinic machines, and even that use is classed as investigational by the AUA. Consumer devices generally produce radial pressure waves, which are physically different and lose energy near the surface, so the trial results do not transfer.

### How much does The Phoenix cost?

About $879, frequently discounted to around $704, with financing quoted at roughly $29 to $43 a month. It is a one-off purchase with nothing recurring.

### Is it cheaper than in-office shockwave therapy?

Yes — in-office sessions run $400 to $600 each and a course is usually six or more. But that comparison assumes the two deliver the same treatment, and the evidence that a consumer handheld matches a focused clinical device is missing. A cheaper version of an unproven therapy is not a bargain.

### Who should not use it?

Anyone with a penile implant, an active infection, a bleeding disorder or on anticoagulants without advice, Peyronie's disease or an unassessed penile lesion, or a cancer diagnosis involving the area. There is no clinician in this purchase to screen for any of that, which is precisely the problem.

### Will it fix ED permanently?

Nothing on this site fixes ED permanently, and the durability of shockwave benefit past a year is poorly established even in the clinical studies. Treating a permanent-cure claim with scepticism is the correct response wherever you encounter it.

### What should I do instead?

Get assessed, because ED is frequently the first sign of vascular disease. Then work through the options with settled evidence — PDE5 inhibitors, a vacuum device, pelvic floor training, sex therapy, and treating the underlying cause. All of them cost less than $879 and all of them have better evidence behind them.

## Sources

- American Urological Association. [Erectile Dysfunction: AUA Guideline](https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline) (2018)
- U.S. Food and Drug Administration. [Device registration and listing — what it does and does not mean](https://www.fda.gov/medical-devices/how-study-and-market-your-device/device-registration-and-listing)
- National Library of Medicine. [ClinicalTrials.gov — find studies you can join](https://clinicaltrials.gov/)
- National Library of Medicine. [PubMed — search the primary literature](https://pubmed.ncbi.nlm.nih.gov/)
- Federal Trade Commission. [Health Products Compliance Guidance](https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance)

## Related pages

- [The Phoenix Review: $879 for an Investigational Therapy, Self-Administered](https://www.edtreatmentguides.com/the-phoenix-reviews/phoenix-device)
- [Shockwave Therapy for ED: What the Evidence Actually Shows](https://www.edtreatmentguides.com/treatments/shockwave-therapy)
- [Shockwave vs PRP: Comparing Two Treatments You Probably Should Not Buy](https://www.edtreatmentguides.com/compare/shockwave-vs-prp)
- [What to Do When ED Medication Doesn't Work](https://www.edtreatmentguides.com/guides/when-medication-fails)
- [Best ED treatments without a prescription](https://www.edtreatmentguides.com/best-otc-ed-treatments)

---

_This page is general health information, not medical advice. It cannot account for your own history, medications or risk factors. Talk to a licensed clinician before starting, stopping or changing any treatment._

_Canonical URL: https://www.edtreatmentguides.com/the-phoenix-reviews — HTML for people, Markdown for agents._